Instruction for use: Ervevax

Dosage form: Lyophilizate for the preparation of solution

Active substance: Vaccinum ad prophylaxim rubeollae vivum

ATX

J07BJ01 Rubella live weakened virus

Pharmacological group

Vaccines, serums, phages and toxoids

Nosological classification (ICD-10)

Z24.5 The need for immunization against rubella alone

Composition and release form

1 vaccination dose of vaccine contains vaccine strain Wistar RA 27/3 rubella virus not less than 1000 TCID50, neomycin B sulfate not more than 25 μg; In vials of 1 or 10 doses, complete with a solvent in ampoules (water for injection); In a box of 100 or 50 bottles, or in a vial 1 dose, complete with a solvent in the ampoule (water for injection) and a syringe, in the box 1 set.

Characteristic

White with a slightly pinkish hue, the lyophilized powder compressed into a tablet (in the solution has a color from light orange to light red) is a preparation of a highly attenuated strain Wistar RA 27/3 of the rubella virus, cultivated in human diploid cells.

Pharmachologic effect

Mode of action - Immunostimulating.

Dosing and Administration

For vaccination of children 12-15 months and 6 years (according to the national calendar), as well as adolescent girls and women of childbearing age outside of pregnancy. SC, it is supposed IM, on 0,5 ml. Before injection, the powder is dissolved with the applied solvent - water for injection.

Storage conditions of the drug Ervevax

In the refrigerator, at a temperature of 2-8 ° C. Solvent - at a temperature of 2-25 ° C.

Keep out of the reach of children.

The shelf life of the drug Ervevax

2 years.

Do not use beyond the expiration date printed on the package.